Withdrawn
Piracetam for Treatment of Cocaine Addiction, Phase II
Led by University of Pennsylvania · Updated on 2017-03-30
N/A
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
The purpose of this study is to follow patients in Phase I of an inpatient study in an eight week open label assessment of piracetam in an outpatient treatment program.
CONDITIONS
Brief Title
Piracetam for Treatment of Cocaine Addiction, Phase II - 4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here